Intensification of polypharmacy glucose-lowering treatment in type-2 diabetes: when to be cautious?
Department of Endocrinology, University of Nantes, 44000 Nantes, France. Bernard.Charbonnel@univ-nantes.fr
Bernard
B
Charbonnel
D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D011307:Drug Prescriptions; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D019338:Polypharmacy; D018570:Risk Assessment
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; C517652:hemoglobin A1c protein, human